8 December 2014
Preliminary research has found that a drug used to treat Parkinson's disease could be safe for the heart.
A study presented at EuroEcho-Imaging 2014 by Dr Hilal Erken Pamukcu, cardiologist at Ankara Diskapi Education and Research Hospital, could have great implications for the one per cent of the population over 60 that suffer from Parkinson's.
Dr Erken Pamukcu said the use of ergot-derived dopamine agonists were used in the past but they are not favoured now as many neurologists are concerned that they caused heart problems, such as fibrotic heart valve disease and scarring in other tissues.
The current study was designed to investigate whether the use of non-ergot derived dopamine agonists, could be associated with heart failure. The team found that these drugs had the same measurements as patients taking a drug commonly used in Parkinson's disease that does not have any adverse cardiac effects.
Dr Erken Pamukcu said: "We did not detect any evidence of asymptomatic myocardial dysfunction or deterioration of systolic function in patients taking pramipexole or ropinirole."
Posted by Jeanette Royston
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.